查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
伤口敷料去除剂的全球市场 - 2022-2029
市场调查报告书
商品编码
1140693

伤口敷料去除剂的全球市场 - 2022-2029

Global Wound Debridement Products Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

在预测期间（2022-2029 年），伤口敷料的市场规模预计将以 5.9% 的复合年增长率增长。

伤口敷料是从人体伤口中去除异物、死组织和有害物质的过程。伤口敷料去除剂产品有助于减少干扰伤口癒合的有害物质。

市场动态

全球伤口敷料市场的驱动力是人口老龄化加剧、糖尿病相关伤口发病率上升、烧伤率上升、产品技术进步以及对伤口护理治疗和管理的认识提高。该计划的驱动力通过肥胖水平的增长和报销政策。

预计产品的技术进步将推动市场增长。

一次性使用负压疗法 (NPWT) 的引入正在取得进展，主要是在家庭护理领域。此外，超声设备的推出有望推动伤口清创产品市场。超声波设备具有诸如区分不易腐烂和易腐烂组织的能力等优点。这些设备有助于破坏生物膜和细菌，而不会损坏血管。同样在 2019 年 8 月 13 日，赫瑞瓦特大学的工程师开发了一种微型电子传感器，可以帮助医务人员通过“听到”伤口来治癒伤口。这种微型传感器有助于监测绷带下组织的微观变化。

此外，正在进行的研究活动有望□□提振市场。例如，最近由俄亥俄州立大学的一组研究人员于 2019 年 3 月在线发表在《科学报告》杂誌上的一项研究发现，电疗绷带可以杀死伤口周围的细菌，使伤口癒合得更快，据说可以治愈。通过这种方式，产品的技术进步和研究活动的增加将推动市场增长。

约束

然而，伤口敷料产品的高成本和接受伤口敷料剂后可能出现的并发症正在阻碍市场。例如，出血、机械伤口敷料产品去除健康组织以及可能因污染引起的感染等并发症可能会限制市场。

行业分析

伤口敷料去除剂市场根据各种行业因素（包括未满足的需求、定价分析、供应链分析和监管分析）对市场进行了深入分析。

细分分析

在伤口敷料去除剂市场中，凝胶部分预计将占据最大的市场份额。

凝胶部分将在 2021 年占据最大的市场份额。好处包括无刺激性、出血少和安□□全去除死组织而不感染。使用凝胶的研究活动也可能会刺激市场。此外，越来越多的手术伤口和手术部位感染 (SSI) 患者、慢性伤口（尤其是糖尿病足溃疡）发病率的上升是导致该细分市场增长的主要因素。例如，基于 CS 的水凝胶因其生物相容性和对病原微生物的活性而在伤口癒合中得到了广泛的关注。 Ferreira 等人开发并表征了用洗必泰（2% 和 4%）配製的 CS 凝胶系统。当应用金黄色葡萄球菌菌株时，这种水凝胶系统的抗菌特性和癒合活性可抑制 100% 的细菌生长。因此，对这种凝胶的需求正在增加。因此，根据上述描述，预计这种市场细分将在预测期内占据最大的市场份额。

区域分析

预计北美将占据全球伤口敷料去除剂市场的最大市场份额。

2021 年，北美市场份额最大。由于产品创新、伤口病例增加、医疗保健支出增加以及该地区人口老龄化的增加，这些都是预测期内的驱动因素。例如，美国国立卫生研究院估计，65 岁以上的人口中有 3% 最终会出现伤口。在资源匮乏的国家和其他伤口和溃疡普遍存在的地区，预计发病率会更高。因此，越来越多的伤口正在推动市场。

此外，预计该地区主要参与者对伤口管理的持续研究活动将推动市场发展。 Cedars-Sinai Health System 的 Brennan Spiegel 及其同事于 2019 年 8 月 14 日在开放获取期刊 PLOS ONE 上发表的一项研究发现，治疗性虚拟现实 (VR) 可以减轻伤口护理期间的疼痛、焦虑症、成为一种积极的非药理学分散患者註意力的方式已经很明显。因此，正在进行的研究活动的存在推动了市场。因此，从以上描述来看，预计北美地区在预测期内将占据最大的市场份额。

竞争格局

伤口敷料市场的主要参与者有 B. Braun Melsungen AG、Acelity L.P. Inc.、Smith & Nephew、Coloplast A/S、ConvaTec Group、Paul Hartmann、Molnlycke Health Care、Lohmann & Rauscher、Medline Industries 和 Integra生命科学。

B. Braun Melsungen GmbH

B.Braun 是一家德国医疗器械和药品製造商。 B. Braun 的产品范围包括 5,000 种产品，其中 95% 是内部製造的。公司的产品组合包括输液、营养和疼痛产品、输液泵和系统、手术器械、缝合材料、髋关节和膝关节植入物、透析机和配件、造口术、消毒和伤口护理产品。它通过五个部门运营：医院护理、Aesculap、B.Brown Avitam、门诊市场 (OPM) 和其他分销。 B.Brown 在 64 个国家/地区开展业务，并在医疗保健行业的 18 个治疗领域开发产品。

产品组合

Askina 纱布压缩，消毒。 Askina 纱布压缩是一种无菌纱布压缩，通过折迭切割端而设计。由 100% 棉製成。

好处

  • 吸水性好
  • 让空气通过
  • 柔软柔软
  • 提供 8 层或 12 层。

全球伤口敷料去除剂市场报告提供对大约 45 多个市场数据表和 40 多个图表的访问。

内容

第1章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

  • 按产品划分的市场细分
  • 按伤口类型划分的市场细分
  • 按方法划分的市场细分
  • 最终用户的市场细分

第 4 章市场动态

  • 市场影响因素
    • 驱动程序
      • 糖尿病和肥胖症的增加
      • 产品中的技术进步
    • 限制因素
      • 去除伤口敷料后的潜在并发症
    • 商机
    • 影响分析

第5章行业分析

  • 波特五力分析
  • 监管分析
  • 供应链分析
  • 定价分析
  • 未满足的需求分析

第 6 章按产品分类

  • 凝胶
    • 超声波设备
    • 手术器械
    • 软膏/乳霜
    • 医用纱布
    • 机械清创垫
    • 其他

第 7 章按伤口类型

  • 烧伤
  • 糖尿病足溃疡
  • 褥疮
  • 静脉性腿部溃疡
  • 手术伤口和外伤
  • 其他

第8章方法

  • 手术方式
  • □法
  • 自溶法
  • 机械法
  • 其他

第 9 章，最终用户

  • 专科诊所
  • 医院
  • 居家护理
  • 其他

第 10 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 11 章竞争格局

  • 竞争场景
  • 市场定位/市场份额分析
  • 併购分析

第 12 章公司简介

  • B.Braun Melsungen AG。
    • 公司概况
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • Acelity L.P., Inc.
  • Smith & Nephew
  • Coloplast A/S
  • ConvaTec Group
  • Paul Hartmann
  • Molnlycke Health Care
  • Lohmann & Rauscher
  • Medline Industries
  • Integra Lifesciences.（"List not exhaustive"）

第13章 重要考察

第14章 DataM

简介目录
Product Code: DMMD1730

Market Overview

Wound Debridement Products Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 5.9% during the forecast period (2022-2029).

Wound Debridement is a process to eliminate foreign invaders, dead tissues, and toxic substances from human wounds. Wound Debridement Products products aid in lowering the poisonous materials that prevent the wounds from getting healed.

Market Dynamics

The global wound Debridement Products Market is driven by the increase in the aging population, rise in prevalence of diabetes and associated wounds, an increasing number of burn injuries, technological advancements in products, awareness programs for wound care treatment and management, growth in obesity levels and reimbursement policies.

The technological advancements in the products are expected to drive the market growth.

The introduction of single-use negative pressure therapy (NPWT), primarily in-home care settings, is gaining traction. Further, the introduction of ultrasonic devices is expected to drive the wound Debridement Products market. Ultrasonic devices offer benefits like the capacity to differentiate between non-viable and viable tissues. These devices aid in destroying biofilms and bacteria without causing damage to blood vessels. Also, on August 13, 2019, Engineers at Heriot-Watt University developed a tiny electronic sensor that will help medics to heal wounds by "listening" to them. The microsensor aids in monitoring the tiny, microscale changes in tissue that are taking place below the bandages.

Moreover, ongoing research activities are expected to boost the market. For instance, in March 2019, a study published online recently in the journal Scientific Reports by a research team at Ohio State University stated that electroceutical bandages could kill the bacteria around a wound, allowing the wounds to heal faster. Thus, technological advancements in the products and a growing number of research activities drive market growth.

Restraint:

However, the high cost of Debridement Products products and the possible complications after undergoing wound debridement products are hampering the market. For instance, complications such as bleeding, removal of healthy tissues by mechanical Debridement Products, and chances of infection through contamination are likely to restrain the market.

Industry Analysis

The wound debridement products market provides in-depth analysis of the market based on various industry factors such as unmet needs, pricing analysis, supply chain analysis, regulatory analysis etc.

Segment Analysis

Gels segment is expected to hold the largest market share in the wound debridement products market.

The gels segment accounted for the largest market share in 2021. The segment benefits from the advantages, including no inflammation, reduced bleeding, and safe removal of necrotic tissues without causing infection. Also, research activities using gels are likely to bolster the market. Moreover, increasing cases of surgical wounds or Surgical Site Infection (SSI) among patients and rising incidence of chronic wounds, especially diabetic foot ulcers, are among the major factors contributing to the segment growth. For instance, CS-based hydrogels have been intensively engaged in wound healing since they are biocompatible and present activity against pathogenic microorganisms. Ferreira et al. developed and characterized a CS gel system associated with chlorhexidine (2% and 4%). This hydrogel system's antibacterial properties and healing activity showed 100% inhibition of bacterial growth when strain S. aureus was applied. Therefore, there is an increase in the demand for the gel. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North American region is expected to hold the largest market share in the global wound debridement products market.

North America accounted for the largest market share in 2021. Owing to the product innovations, an increasing number of wound cases, increasing healthcare spending, and the growing aging population in this region are the factors to drive in the forecast period. For instance, the National Institute of Health has estimated that 3% of the population 65 years and above would have a wound at some time. An even higher incidence rate is expected, owing to the traumatic injuries and ulcers endemic in resource-poor countries to other regions. Thus, the rising number of wounds is driving the market.

Moreover, the ongoing research activities for wound management by the key players in the region are expected to boost the market. A study published on August 14, 2019, in the open-access journal PLOS ONE by Brennan Spiegel of Cedars-Sinai Health System and colleagues found that therapeutic virtual reality (VR) is emerging as an active, non-pharmacological treatment modality for pain, anxiety disorders, and distract patients during wound care. Thus, the presence of ongoing research activities is driving the market. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the wound debridement products market are B. Braun Melsungen AG, Acelity L.P. Inc., Smith & Nephew, Coloplast A/S, ConvaTec Group, Paul Hartmann, Molnlycke Health Care, Lohmann & Rauscher, Medline Industries, and Integra Lifesciences.

B. Braun Melsungen AG:

B. Braun is a German manufacturer of medical and pharmaceutical devices. The B. Braun product line includes 5,000 items, 95 percent of which are manufactured by the company. The company's product portfolio includes infusion, nutrition, pain therapy products, infusion pumps and systems, surgical instruments, suture materials, hip and knee implants, dialysis equipment and accessories, ostomy, disinfection, and wound care products. The company operates its business through five divisions: hospital care, Aesculap, B. Braun Avitum, out-patient market (OPM) and other sales. B. Braun has a presence in 64 countries and develops products in 18 therapy fields of the healthcare industry.

Product Portfolio:

Askina Gauze Compress, sterile: Askina Gauze Compress is a sterile gauze compress designed with cut edges folded. It is made of 100% cotton.

Advantages

  • Good absorbency
  • Permeable to air
  • Soft and supple
  • Available at 8-PLY or 12-PLY.

The global wound debridement products market report would provide an access to an approx. 45+market data table, 40+figures

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Product
  • 3.2. Market Snippet by Wound type
  • 3.3. Market Snippet by Method
  • 3.4. Market Snippet by End-user

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The Rising incidence of diabetes and obesity
      • 4.1.1.2. The presence of technological advancements in products
    • 4.1.2. Restraints
      • 4.1.2.1. The possible complications after wound debridement
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Regulatory Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. Pricing Analysis
  • 5.5. Unmet Needs

6. By Product

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Market Attractiveness Index, By Product type Segment
  • 6.2. Gels*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
    • 6.2.3. Ultrasonic Devices
    • 6.2.4. Surgical devices
    • 6.2.5. Ointments and Creams
    • 6.2.6. Medical Gauze
    • 6.2.7. Mechanical Debridement ProductsPads
    • 6.2.8. Others

7. By Wound type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound type
    • 7.1.2. Market Attractiveness Index, By Wound type Segment
  • 7.2. Burns*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
  • 7.3. Diabetic Foot Ulcers
  • 7.4. Pressure Ulcers
  • 7.5. Venous Leg Ulcers
  • 7.6. Surgical & Traumatic Wounds
  • 7.7. Others

8. By Method

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
    • 8.1.2. Market Attractiveness Index, By Method Segment
  • 8.2. Surgical Method*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
  • 8.3. Enzymatic Method
  • 8.4. Autolytic Method
  • 8.5. Mechanical Method
  • 8.6. Others

9. By End-user

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user Segment
    • 9.1.2. Market Attractiveness Index, By End-user Segment
  • 9.2. Specialty Clinics *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
  • 9.3. Hospitals
  • 9.4. Home care
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound type
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 10.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. The U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound type
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 10.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. The U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Italy
      • 10.3.7.5. Spain
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound type
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 10.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound type
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 10.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. Australia
      • 10.5.7.5. Rest of Asia Pacific
  • 10.6. The Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound type
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
    • 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. B. Braun Melsungen AG.*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Acelity L.P., Inc.
  • 12.3. Smith & Nephew
  • 12.4. Coloplast A/S
  • 12.5. ConvaTec Group
  • 12.6. Paul Hartmann
  • 12.7. Molnlycke Health Care
  • 12.8. Lohmann & Rauscher
  • 12.9. Medline Industries
  • 12.10. Integra Lifesciences. ("List not exhaustive")

13. Premium Insights

14. DataM Intelligence

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us